WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics. - Grauer, Steven; Graf, Radka; Navarra, Rachel; Sung, Amy; Logue, Sheree; Stack, Gary; Huselton, Christine; Liu, Zhi; Comery, Thomas; Marquis, Karen; Rosenzweig-Lipson, Sharon (Psychopharmacology, 2009)